WHO’s latest report on pharmaceuticals in drinking water includes a brief discussion of the acceptable daily intake (ADI) and minimum therapeutic dose (MTD) approaches used to assess the human health risks associated with these chemicals. WHO concludes that adverse health effects are very unlikely to arise from exposure to pharmaceuticals in the drinking water, as only very low levels have been detected (generally more than 1000 times lower than the MTD).

World Health Organization (2012). Pharmaceuticals in drinking water.

http://apps.who.int/iris/bitstream/10665/44630/1/9789241502085_eng.pdf

 

The above item was taken from the August 2012 issue of Toxicology and Regulatory News which is sent automatically to members of bibra (click here for more details).

News Home Guest Write For Us? Contact Us